Ginwa Enterprise Group Inc (SHG:600080) — Market Cap & Net Worth
Market Cap & Net Worth: Ginwa Enterprise Group Inc (600080)
Ginwa Enterprise Group Inc (SHG:600080) has a market capitalization of $395.46 Million (CN¥2.70 Billion) as of May 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #13766 globally and #4331 in its home market, demonstrating a -8.70% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ginwa Enterprise Group Inc's stock price CN¥7.24 by its total outstanding shares 373270285 (373.27 Million). Analyse 600080 operating cash flow to see how efficiently the company converts income to cash.
Ginwa Enterprise Group Inc Market Cap History: 2015 to 2026
Ginwa Enterprise Group Inc's market capitalization history from 2015 to 2026. Data shows change from $759.19 Million to $395.46 Million (-2.74% CAGR).
Ginwa Enterprise Group Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ginwa Enterprise Group Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.73x
Ginwa Enterprise Group Inc's market cap is 0.73 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.72x
Ginwa Enterprise Group Inc's market cap is 5.72 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $759.19 Million | $730.14 Million | $25.38 Million | 1.04x | 29.91x |
| 2016 | $665.41 Million | $666.65 Million | $27.30 Million | 1.00x | 24.37x |
| 2017 | $434.01 Million | $757.18 Million | $53.46 Million | 0.57x | 8.12x |
| 2018 | $381.57 Million | $745.16 Million | $38.32 Million | 0.51x | 9.96x |
| 2019 | $323.33 Million | $754.54 Million | $25.90 Million | 0.43x | 12.48x |
| 2020 | $301.46 Million | $668.18 Million | $37.74 Million | 0.45x | 7.99x |
| 2021 | $465.92 Million | $534.04 Million | -$18.16 Million | 0.87x | N/A |
| 2022 | $426.59 Million | $579.37 Million | $33.46 Million | 0.74x | 12.75x |
| 2023 | $406.93 Million | $565.40 Million | -$42.89 Million | 0.72x | N/A |
| 2024 | $426.59 Million | $585.46 Million | $74.61 Million | 0.73x | 5.72x |
Competitor Companies of 600080 by Market Capitalization
Companies near Ginwa Enterprise Group Inc in the global market cap rankings as of May 7, 2026.
Key companies related to Ginwa Enterprise Group Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #501 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #530 globally with a market cap of $50.06 Billion USD ( CN¥342.11 Billion CNY).
- Zoetis Inc (NYSE:ZTS): Ranked #541 globally with a market cap of $49.01 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #574 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #501 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.06 Billion | CN¥53.63 |
| #541 | Zoetis Inc | NYSE:ZTS | $49.01 Billion | $111.22 |
| #574 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $43.83 |
Ginwa Enterprise Group Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Ginwa Enterprise Group Inc's market cap moved from $759.19 Million to $ 395.46 Million, with a yearly change of -2.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥395.46 Million | -3.98% |
| 2025 | CN¥411.84 Million | -3.46% |
| 2024 | CN¥426.59 Million | +4.83% |
| 2023 | CN¥406.93 Million | -4.61% |
| 2022 | CN¥426.59 Million | -8.44% |
| 2021 | CN¥465.92 Million | +54.55% |
| 2020 | CN¥301.46 Million | -6.76% |
| 2019 | CN¥323.33 Million | -15.26% |
| 2018 | CN¥381.57 Million | -12.08% |
| 2017 | CN¥434.01 Million | -34.78% |
| 2016 | CN¥665.41 Million | -12.35% |
| 2015 | CN¥759.19 Million | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of Ginwa Enterprise Group Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $395.46 Million USD |
| MoneyControl | $395.46 Million USD |
| MarketWatch | $395.46 Million USD |
| marketcap.company | $395.46 Million USD |
| Reuters | $395.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ginwa Enterprise Group Inc
Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also in… Read more